* Sofinnova Venture Partners reports 6.6 pct passive stake
in Audentes Therapeutics as of July 20 - SEC filing
Source text: http://bit.ly/2aKKMdl
Further company coverage:
(Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223
8780)
Read more
No comments:
Post a Comment